Healthpeak Properties, Inc. $DOC Stock Position Raised by Morningstar Investment Management LLC

Morningstar Investment Management LLC lifted its position in Healthpeak Properties, Inc. (NYSE:DOC) by 8.6% in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 310,140 shares of the real estate investment trust’s stock after acquiring an additional 24,595 shares during the quarter. Morningstar Investment Management LLC’s holdings in Healthpeak Properties were worth $5,096,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. WPG Advisers LLC raised its stake in Healthpeak Properties by 270.2% during the 4th quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock valued at $26,000 after purchasing an additional 1,197 shares during the period. Advocate Investing Services LLC acquired a new stake in shares of Healthpeak Properties in the fourth quarter worth $26,000. Elyxium Wealth LLC acquired a new stake in shares of Healthpeak Properties in the fourth quarter worth $31,000. Clearstead Advisors LLC grew its holdings in shares of Healthpeak Properties by 166.3% during the fourth quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock valued at $31,000 after buying an additional 1,216 shares in the last quarter. Finally, CYBER HORNET ETFs LLC purchased a new position in shares of Healthpeak Properties during the second quarter valued at $33,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Price Performance

Shares of NYSE:DOC opened at $22.29 on Friday. The firm has a market cap of $15.37 billion, a price-to-earnings ratio of 69.67, a P/E/G ratio of 3.43 and a beta of 1.02. Healthpeak Properties, Inc. has a 1 year low of $15.70 and a 1 year high of $22.77. The company has a current ratio of 2.96, a quick ratio of 2.96 and a debt-to-equity ratio of 1.15. The business has a fifty day simple moving average of $20.74 and a 200 day simple moving average of $18.45.

Healthpeak Properties (NYSE:DOC) last issued its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The firm had revenue of $752.95 million for the quarter, compared to the consensus estimate of $694.59 million. During the same quarter in the previous year, the company posted $0.46 earnings per share. The business’s quarterly revenue was up 7.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. As a group, sell-side analysts predict that Healthpeak Properties, Inc. will post 1.75 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The company also recently declared a monthly dividend, which will be paid on Friday, September 25th. Stockholders of record on Monday, September 14th will be issued a dividend of $0.1017 per share. This represents a c) annualized dividend and a dividend yield of 5.5%. The ex-dividend date is Monday, September 14th. Healthpeak Properties’s payout ratio is currently 381.25%.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the company. Wells Fargo & Company increased their price objective on Healthpeak Properties from $20.00 to $22.00 and gave the stock an “equal weight” rating in a research note on Wednesday, July 15th. UBS Group lifted their target price on Healthpeak Properties from $19.00 to $21.50 and gave the company a “neutral” rating in a research note on Wednesday, July 8th. Evercore downgraded Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 target price on the stock. in a report on Monday, May 11th. Royal Bank Of Canada increased their price target on shares of Healthpeak Properties from $20.00 to $21.00 and gave the stock an “outperform” rating in a research report on Thursday, May 14th. Finally, BMO Capital Markets raised their price target on shares of Healthpeak Properties from $20.00 to $24.00 and gave the stock an “outperform” rating in a report on Monday, June 15th. Four equities research analysts have rated the stock with a Buy rating and fifteen have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Healthpeak Properties has a consensus rating of “Hold” and a consensus price target of $20.62.

Insider Activity at Healthpeak Properties

In related news, insider Scott R. Bohn sold 10,989 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total value of $213,736.05. Following the completion of the sale, the insider owned 7,636 shares of the company’s stock, valued at approximately $148,520.20. The trade was a 59.00% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 0.23% of the company’s stock.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.